High frequency of blackwater fever among children presenting to hospital with severe febrile illnesses in eastern Uganda

Clinical Infectious Diseases

Volumn 64, Issue 7, 2017, Pages 939-946

  Olupot Olupot, Peter ^a,b   Engoru, Charles ^c   Uyoga, Sophie ^d   Muhindo, Rita ^a   Macharia, Alex ^d   Kiguli, Sarah ^e   Opoka, Robert O ^e   Akech, Samuel ^d   Ndila, Carolyne ^d   Nyeko, Richard ^f   Mtove, George ^g   Nteziyaremye, Julius ^a   Chebet, Martin ^a,b   George, Elizabeth C ^h   Babiker, Abdel G ^h   Gibb, Diana M ^h   Williams, Thomas N ^a,b,d,i   Maitland, Kathryn ^a,b,d,i  

^a Mbale Regional Referral Hospital Clinical Research Unit   (Uganda)

^b BUSITEMA UNIVERSITY   (Uganda)

^c Soroti Regional Referral Hospital   (Uganda)

^d Kenya Medical Research Institute Wellcome Trust Research Programme   (Uganda)

^e MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^f Saint Mary Hospital   (Uganda)

^g Teule Hospital   (Tanzania)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

African child; Blackwater fever; Haemoglobinopathies; Hemoglobinuria; Malaria

Indexed keywords

ARTESUNATE; HEMOGLOBIN; QUININE; BIOLOGICAL MARKER; GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

ADOLESCENT; ADULT; ALPHA THALASSEMIA; ANEMIA; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; JAUNDICE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; METABOLIC ACIDOSIS; PARASITEMIA; PREVALENCE; PRIORITY JOURNAL; SICKLE CELL TRAIT; UGANDA; AGE; COMPLICATION; ERYTHROCYTE; GENETIC POLYMORPHISM; GENETICS; HEMOGLOBINOPATHY; INFANT; METABOLISM; MUTATION; OUTCOME ASSESSMENT; PARASITOLOGY; PHENOTYPE; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; URINALYSIS;

AGE FACTORS; BIOMARKERS; BLACKWATER FEVER; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; HEMOGLOBINOPATHIES; HUMANS; INFANT; MALE; MUTATION; PATIENT OUTCOME ASSESSMENT; PHENOTYPE; POLYMORPHISM, GENETIC; PREVALENCE; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; UGANDA; URINALYSIS;

EID: 85018289021     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix003     Document Type: Article

References (32)

1. Connolly RM. African haemoglobinuric fever, commonly called blackwater fever. Br Med J 1898; 2:882-5.
2. Mate-Kole MO, Yeboah ED, Affram RK, Adu D. Blackwater fever and acute renal failure in expatriates in Africa. Ren Fail 1996; 18: 525-31.
3. Bruce-Chwatt LJ. Quinine and the mystery of blackwater fever. Acta Leiden 1987; 55:181-96.
4. Patel A, Lodha A, Chaudhuri J, Jadia P, Joshi T, Dalal J. Formulation, process development and evaluation of artemether and lumefantrine soft gelatin capsule. J Pharm Bioallied Sci 2012; 4(suppl 1):S98-100.
5. Tran TH, Day NP, Ly VC, et al. Blackwater fever in southern Vietnam: A prospective descriptive study of 50 cases. Clin Infect Dis 1996; 23:1274-81.
6. George CR. Blackwater fever: The rise and fall of an exotic disease. J Nephrol 2009; 22(suppl 14):120-8.
7. Severe malaria. Trop Med Int Health 2014; 19(suppl 1): 7-131.
8. Bodi JM, Nsibu CN, Longenge RL, et al. Blackwater fever in Congolese children: A report of clinical, laboratory features and risk factors. Malar J 2013; 12:205.
9. Delacollette C, Taelman H, Wery M. An etiologic study of hemoglobinuria and blackwater fever in the Kivu Mountains, Zaire. Ann Soc Belg Med Trop 1995; 75:51-63.
10. Malaria for Malaria Venture. Experts Group Meeting on delayed haemolytic anaemia following treatment with injectable artesunate. Report. Vienna, Austria, 2013. Available at: http://www.mmv.org/newsroom/events/expert-group-meeting-safety-profile-injectable-artesunate. Accessed 1 July 2016.
11. Rolling T, Agbenyega T, Issifou S, et al. Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria-A double-center prospective study. J Infect Dis 2014; 209:1921-8.
12. Paczkowski MM, Landman KL, Arguin PM; Centers for Disease Control and Prevention (CDC). Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria-United States, 2008 and 2013. MMWR Morb Mortal Wkly Rep 2014; 63:753-5.
13. Maitland K, Kiguli S, Opoka RO, et al; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-95.
14. Dondorp AM, Desakorn V, Pongtavornpinyo W, et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2005; 2:e204.
15. Suchdev PS, Ruth LJ, Earley M, Macharia A, Williams TN. The burden and consequences of inherited blood disorders among young children in western Kenya. Matern Child Nutr 2014; 10:135-44.
16. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995; 332:1399-404.
17. Waller D, Krishna S, Crawley J, et al. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis 1995; 21:577-87.
18. World Health Organization, Communicable Diseases Cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000; 94(suppl 1): S1-90.
19. Ahmed I, Olowe O. Haemoglobinuria in Nigerian children. Afr J Med Sci 1971; 2:101-8.
20. Ajetunmobi WA, Orimadegun AE, Brown BJ, et al. Haemoglobinuria among children with severe malaria attending tertiary care in Ibadan, Nigeria. Malar J 2012; 11:336.
21. Aloni NM, Nsangu M, Kunuanunua T, Kadima TB, Muanda TF. Haemolytic crisis of blackwater fever following artemether-lumefantrine intake [in French]. Bull Soc Pathol Exot 2010; 103:296-8.
22. Kunuanunua TS, Nsibu CN, Bodi JM, et al. Severe malaria in children: A descriptive report from Kinshasa, the Democratic Republic of Congo. J Trop Pediatr 2015; 61:272-8.
23. O'Donnell A, Weatherall DJ, Taylor AM, Reeder JC, Allen SJ. Muscle cell injury, haemolysis and dark urine in children with falciparum malaria in Papua New Guinea. Trans R Soc Trop Med Hyg 2006; 100:817-25.
24. Rogier C, Imbert P, Tall A, Sokhna C, Spiegel A, Trape JF. Epidemiological and clinical aspects of blackwater fever among African children suffering frequent malaria attacks. Trans R Soc Trop Med Hyg 2003; 97:193-7.
25. Trang TT, Phu NH, Vinh H, et al. Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis 1992; 15:874-80.
26. Dondorp AM, Fanello CI, Hendriksen IC, et al; AQUAMAT Group. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010; 376:1647-57.
27. Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:457-68.
28. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010; 376:2018-31.
29. Foy H, Kondi A. The correlation between blackwater fever, malaria, quinine and atebrin. Ann Trop Med Parasitol 1950; 44:309-18.
30. O'Connell KA, Gatakaa H, Poyer S, et al. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malar J 2011; 10:326.
31. Rolling T, Agbenyega T, Krishna S, Kremsner PG, Cramer JP. Delayed haemolysis after artesunate treatment of severe malaria-review of the literature and perspective. Travel Med Infect Dis 2015; 13:143-9.
32. Jauréguiberry S, Ndour PA, Roussel C, et al; French Artesunate Working Group. Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. Blood 2014; 124:167-75.